StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

by · The Markets Daily

StockNews.com started coverage on shares of Milestone Scientific (NYSE:MLSS – Free Report) in a research report report published on Friday. The firm issued a hold rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and issued a $1.25 price objective on shares of Milestone Scientific in a research report on Wednesday, November 20th.

Check Out Our Latest Stock Analysis on MLSS

Milestone Scientific Trading Up 16.0 %

Shares of MLSS stock opened at $0.93 on Friday. Milestone Scientific has a twelve month low of $0.52 and a twelve month high of $1.10. The stock has a 50 day moving average of $0.81 and a 200 day moving average of $0.86. The stock has a market cap of $72.05 million, a P/E ratio of -13.21 and a beta of 1.10.

Insider Transactions at Milestone Scientific

In other Milestone Scientific news, Director Leonard Osser sold 107,984 shares of the business’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now directly owns 4,606,882 shares in the company, valued at $4,284,400.26. The trade was a 2.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders have sold 128,193 shares of company stock valued at $116,234 over the last ninety days. Insiders own 24.75% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the company. World Investment Advisors LLC acquired a new position in shares of Milestone Scientific in the third quarter valued at approximately $91,000. Y Intercept Hong Kong Ltd purchased a new position in Milestone Scientific in the third quarter valued at $48,000. Finally, Geode Capital Management LLC raised its stake in Milestone Scientific by 6.4% in the third quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock valued at $480,000 after buying an additional 31,572 shares in the last quarter. 5.79% of the stock is currently owned by hedge funds and other institutional investors.

About Milestone Scientific

(Get Free Report)

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.

Read More